Insights

Gathering insights about Ncardia…

Similar companies to Ncardia

Ncardia Tech Stack

Ncardia uses 8 technology products and services including AdRoll, Google Font API, Vue.js, and more. Explore Ncardia's tech stack below.

AdRoll
Advertising
Google Font API
Font Scripts
Vue.js
Javascript Frameworks
Microsoft
Miscellaneous
HTTP/3
Miscellaneous
UIKit
UI Frameworks
VMware
Virtualisation Software
Linkedin
Widgets

Media & News

Ncardia launches panel of ready-to-use assays.
Ncardia launches panel of ready-to-use assays to streamline screening and selection of new therapeutic candidates.
Sep 10, 2024 | bioinformant.com
Ncardia launched comprehensive drug discovery platform for therapeutic research in obstructive hypertrophic cardiomyopathy on Apr 1st '20.
For instance, in April 2020, Ncardia launched a comprehensive drug discovery platform for therapeutic research in obstructive hypertrophic cardiomyopathy (HCM).
Jan 19, 2023 | www.einnews.com
Ncardia launched Cellistic on Apr 1st '22.
April 26, 2022 -- Ncardia has announced the launch of Cellistic, a new cell therapy manufacturing business whose focus is to optimize Ncardia’s process development and production capabilities related to induced pluripotent stem cells (iPSCs).
Apr 25, 2022 | www.scienceboard.net
Kiniciti partnered with Ncardia on Oct 17th '21.
Later in November, Kiniciti announced its first strategic partnership with Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy.
Apr 25, 2022 | biospring.com
Ncardia hired Andy Holt as Chief Commercial Officer on Feb 24th '22.
Ncardia, leader in stem cell-based solutions for drug discovery and cell therapy, announces the appointment of Andy Holt as Chief Commercial Officer.
Feb 24, 2022 | www.businesswire.com
Ncardia receives financing of $60M.
Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, announced that it has secured more than $60 million in capital through a strategic partnership with Kiniciti, a U.S.-based investment platform focused on strengthening the cell and gene therapy ecosystem worldwide.
Nov 16, 2021 | www.businesswire.com
Ncardia launched Xpress.4U LightPace Cor.4U on Jan 1st '18.
For instance, in 2018, Ncardia, a company working for drug discovery using stem cell, launched Xpress.4U LightPace Cor.4U, a kit for improving and simplifying the use of optical pacing of cardiomyocytes, a human induced pluripotent stem cell.
Oct 29, 2021 | thehostonline.co.uk

Ncardia's Email Address Formats

Ncardia uses at least 1 format(s):

Ncardia Email Formats	Example	Percentage
First.Last@ncardia.com	John.Doe@ncardia.com	88%
First.MiddleLast@ncardia.com	John.MichaelDoe@ncardia.com	8%
FirLast@ncardia.com	JohDoe@ncardia.com	3%
First@ncardia.com	John@ncardia.com	1%

Frequently Asked Questions

Where is Ncardia's headquarters located?

Ncardia's main headquarters is located at Ncardia Leiden, Galileiweg 8 Building BioPartner 1 Leiden, South Holland 2333 BD NL. The company has employees across 2 continents, including EuropeNorth America.

What is Ncardia's official website and social media links?

Ncardia's official website is ncardia.com and has social profiles on LinkedIn.

How much revenue does Ncardia generate?

As of November 2024, Ncardia's annual revenue reached $35M.

What is Ncardia's SIC code NAICS code?

Ncardia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ncardia have currently?

As of November 2024, Ncardia has approximately 61 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: G. M.CSO: H. B.Vice President Marketing: D. S.. Explore Ncardia's employee directory with LeadIQ.

What industry does Ncardia belong to?

Ncardia operates in the Biotechnology Research industry.

What technology does Ncardia use?

Ncardia's tech stack includes AdRollGoogle Font APIVue.jsMicrosoftHTTP/3UIKitVMwareLinkedin.

What is Ncardia's email format?

Ncardia's email format typically follows the pattern of . Find more Ncardia email formats with LeadIQ.

How much funding has Ncardia raised to date?

As of November 2024, Ncardia has raised $60M in funding. .

When was Ncardia founded?

Ncardia was founded in 2011.

Ncardia

Biotechnology ResearchSouth Holland, Netherlands51-200 Employees

Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. 

Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery.
We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications.

Explore our website to learn more www.ncardia.com.

Company Overview

Headquarters: Ncardia Leiden, Galileiweg 8 Building BioPartner 1 Leiden, South Holland 2333 BD NL
Website: ncardia.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2011
Employees: 51-200